FDA panel rejects attempt to use psychedelic drug for PTSD treatment

A key FDA advisory committee rejected the use of a psychedelic drug to help patients struggling with PTSD, questioning its safety and effectiveness. The FDA must now decide whether it will follow suit and reject the use of what's known as MDMA. Some patients and researchers had long hoped the government would approve it. Science correspondent Miles O’Brien reports.
Stream your PBS favorites with the PBS app: to.pbs.org/2Jb...
Find more from PBS NewsHour at www.pbs.org/ne...
Subscribe to our KZbin channel: bit.ly/2HfsCD6
Follow us:
TikTok: / pbsnews
Twitter: / newshour
Instagram: / newshour
Facebook: www.pbs.org/new...
Subscribe:
PBS NewsHour podcasts: www.pbs.org/ne...
Newsletters: www.pbs.org/ne...